Rocket One RKTO
NASDAQ RKTO
$0.67 -0.02 (-3.47%)
As of: Sep 9, 2026 · 3:35 PM EDT

Rocket One (RKTO) Shares Outstanding (2017 - 2026)

Rocket One's (RKTO) quarterly Shares Outstanding (Entity) came in at $23.2 million in Q2 2026, up 75.19% year-over-year from $13.2 million in Q2 2025, and up 42.49% quarter-over-quarter from $16.3 million in Q1 2026.

Analysis

Rocket One (RKTO) Shares Outstanding (2017 - 2026) Analysis & Trends

Rocket One has disclosed Shares Outstanding (Entity) across 10 years of filings, most recently posting $23.2 million for Q2 2026.

  • In Q2 2026, Shares Outstanding (Entity) rose 75.19% year-over-year to $23.2 million; the TTM figure through Jun 2026 stood at $23.2 million (up 75.19% YoY), while the FY2025 annual figure was $15.5 million, up 143.36% from the prior year.
  • Shares Outstanding (Entity) came in at $23.2 million for Q2 2026 at Rocket One, up from $16.3 million in the prior quarter.
  • In the past five years, Shares Outstanding (Entity) ranged from a high of $32.2 million in Q2 2022 to a low of $1.3 million in Q3 2022.
  • Average Shares Outstanding (Entity) over 5 years is $10.7 million, with a median of $6.9 million recorded in 2024.
  • Year-over-year, Shares Outstanding (Entity) sank 94.63% in 2022 and soared 199.08% in 2025.
  • Over 5 years, Shares Outstanding (Entity) stood at $1.3 million in 2022, then jumped by 161.82% to $3.4 million in 2023, then soared by 87.0% to $6.4 million in 2024, then soared by 143.36% to $15.5 million in 2025, then jumped by 49.44% to $23.2 million in 2026.
  • Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $23.2 million in Q2 2026, $16.3 million in Q1 2026, and $15.5 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Amgen 211.77 Bn 197.79 Bn 7.24 Bn 540.00 Mn
2 Gilead Sciences 181.13 Bn 177.95 Bn 6.22 Bn 1.24 Bn
3 Vertex Pharmaceuticals 132.24 Bn 124.39 Bn 2.84 Bn 253.70 Mn
4 Regeneron Pharmaceuticals 82.89 Bn 74.89 Bn 3.93 Bn 102.80 Mn
5 Argenx Se 61.56 Bn 56.38 Bn 1.37 Bn 61.30 Mn
6 Moderna 54.38 Bn 49.24 Bn 52.00 Mn 398.00 Mn
7 Alnylam Pharmaceuticals 34.44 Bn 31.13 Bn 992.69 Mn 133.61 Mn
8 Biogen 31.17 Bn 29.89 Bn 1.96 Bn 147.70 Mn
9 Roivant Sciences 30.12 Bn 30.12 Bn 1.16 Mn 720.78 Mn
10 Rocket One 13.80 Mn 5.90 Mn - 20.55 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 20.55 Mn
Mar 31, 2026 15.79 Mn
Dec 31, 2025 13.81 Mn
Sep 30, 2025 13.79 Mn
Jun 30, 2025 13.18 Mn
Mar 31, 2025 12.73 Mn
Dec 31, 2024 6.38 Mn
Sep 30, 2024 6.90 Mn
Jun 30, 2024 6.88 Mn
Mar 31, 2024 4.40 Mn
Dec 31, 2023 3.41 Mn
Sep 30, 2023 3.48 Mn
Jun 30, 2023 3.30 Mn
Mar 31, 2023 2.48 Mn
Dec 31, 2022 1.20 Mn
Sep 30, 2022 1.29 Mn
Jun 30, 2022 31.03 Mn
Mar 31, 2022 23.97 Mn
Dec 31, 2021 22.33 Mn
Sep 30, 2021 23.89 Mn